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DEVELOPMENT OF AN ALCOHOL WITHDRAWAL RISK STRATIFICATION 
TOOL BASED ON PATIENTS REFERRED TO AN ADDICTION LIAISON 
NURSING SERVICE IN GLASGOW
ABSTRACT
Purpose: To develop an Alcohol Withdrawal Syndrome (AWS) risk stratification tool that 
could support the safe discharge of low risk patients from the emergency department.
Design/Methods: A retrospective cohort study that included all patients referred to the acute 
addiction liaison nursing service (AALNS) over one calendar month (n=400, 1st April 2016-
30th April 2016) was undertaken. Bivariate and multivariate modelling identified the 
significant variables that supported the prediction of severe alcohol withdrawal syndrome 
(SAWS) in the cohort population.
Findings: The Glasgow Modified Alcohol Withdrawal Scale (GMAWS), hours since last 
drink, Fast Alcohol Screening Test (FAST), and systolic blood pressure (SBP) correctly 
identified 89% of patients who developed SAWS and 84% of patients that did not. Increasing 
each component by a score of one is associated with an increase in the odds of SAWS by a 
factor of 2.76 (95% CI 2.21, 3.45), 1.31 (95% CI 1.24, 1.37), 1.30 (CI 1.08, 1.57) and 1.22 
(95% CI 1.10, 1.34) respectively. 
Research Limitations: The research was conducted in a single healthcare system that had a 
high prevalence of alcohol dependence syndrome (ADS). Second, the developed risk 
stratification tool was unable to guarantee no risk and lastly, the FAST score previously 
aligned to severe ADS may have influenced the patients highest GMAWS score.  
Originality/ Value: The tool could help redesign the care pathway for emergency department 
patients at low risk of SAWS and link them with community alcohol services better equipped 
to deal with their physical and psychological needs, short and long term, supporting 
engagement, abstinence and prolongation of life.
KEYWORDS: alcohol, general hospital, delirium tremens, alcohol-related seizures, alcohol 
withdrawal syndrome, risk prediction, hospital admission, risk stratification
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INTRODUCTION
Alcohol use is one of the major causes of disease, death and injury globally (World Health 
Organisation, 2014). Excessive alcohol consumption is linked to over 200 physical and 
psychological diseases and has a longstanding association with cardiovascular disease, liver 
cirrhosis and various cancers (World Health Organisation, 2014; Holman et al., 1996). From 
an acute health perspective the greatest impact of problematic alcohol use is witnessed by 
emergency departments,  where at peak times 70% of attendances are alcohol related (Vardy 
et al., 2017; Waye et al., 2015; Stehman & Mycyk, 2013; Manasco. et al., 2012; Forsythe & 
Lee, 2012; The Department of Health, 2008). The primary alcohol reason for hospital 
attendance is alcohol withdrawal syndrome (AWS) which is a risk in people who have 
alcohol dependence syndrome (ADS) when they stop drinking (Vardy et al., 2017). ADS is 
recognised by the International Classification of Disease- Tenth Revision (ICD-10) when a 
person experiences three from a suite of six symptoms in the previous 12 months (World 
Health Organisation, 2016). 
AWS and ADS span a spectrum that range from mild to severe, where mild withdrawal 
requires minimum intervention, and severe alcohol withdrawal syndrome (SAWS) that 
includes alcohol related seizures (ARS) and delirium tremens (DT`s) hospital admission 
(Sutton & Jutel, 2016; Feeney et al., 2015; Passeti et al., 2008). Although SAWS is 
experienced by approximately 10% of people, emergency department physicians are under 
pressure to see patients and make decisions quickly (Vardy et al., 2017). Consequently, a 
high proportion of patients are admitted to hospital acutely for alcohol detoxification incase 
they develop SAWS. The result of this just incase practice is that patients are discharged after 
24 hours and has contributed to the increase in short to zero stay hospital admissions (ISD 
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Scotland, 2017; NHS England, 2016; Maldonado et al., 2015; Pecoraro et al., 2013: Dolman 
& Hawkes, 2005). 
The decision to admit to hospital for alcohol detoxification is not supported by the lack of a 
tool to inform physicians in this decision (Benson et al., 2019; NICE, 2016; Stephens et al., 
2014; Repper-DeLisi et al., 2008). Despite a number of retrospective studies investigating 
risk factors and SAWS, the only protocol located for the identification of low SAWS risk was 
developed by Stephens et al. (2014). The Clinical Institute Withdrawal Assessment- Alcohol 
Revised (CIWA-AR) (Sullivan et al., 1989) was central to the Stephens et al. (2014) protocol 
where SAWS is suspected at a CIWA-AR > 15. While CIWA-AR > 15 necessitated inpatient 
detoxification, patients who had a CIWA-AR < 15 were screened for discharge (Stephens et 
al., 2014).
Detoxification carried out in hospital is up to eight times more costly than outpatient 
treatment, and reduces the likelihood that patients will attend alcohol treatment programmes 
on hospital discharge (Alwyn et al., 2004; Cooper, 1995; Bartu & Saunders, 1994). 
Importantly, outpatient detoxification presents comparable results with inpatient 
detoxification for patient abstinence, engagement, satisfaction and adverse events (Passeti et 
al., 2008). However, the high incidence of alcohol presentations and subsequent admissions 
to hospital are having a detrimental impact on the NHS ability to achieve the Government’s 
waiting time target (ISD Scotland, 2017; NHS England, 2016). In NHS Greater Glasgow & 
Clyde (NHSGGC), the guarantee that 95% of patients will be admitted or discharged within 
four hours of their presentation to the emergency department is achieved in less than 90% of 
cases (ISD Scotland, 2017).  
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NHSGGC provides health care to a population of 1.2 million people and covers six of the 
most deprived post code areas in Scotland. Deprivation in Scotland is captured by the 
Statistical Index of Multiple Deprivation where 1 is the most deprived and 5 the least (ISD 
Scotland, 2017). People living in the most deprived post code areas are eight times more 
likely to attend the emergency department for an alcohol related condition than people from 
more affluent areas (ISD Scotland, 2017; Walsh et al., 2010; The Scottish Government, 
2009). In 2015/16 there were approximately 12,000 alcohol related acute hospital admissions 
in Glasgow (ISD Scotland, 2017). Patients in NHSGGC admitted with an alcohol problem 
are referred to the acute addiction liaison nursing service (AALNS).  The AALNS are a team 
of specialist nurses who provide assessment, treatment planning and onward referral for 
problematic alcohol use patients admitted to hospital (McPherson & Benson, 2011). In 
NHSGGC, the level of a person’s alcohol consumption and AWS symptoms are captured by 
the Glasgow Assessment Management of Alcohol (GAMA) guideline (McPherson et al., 
2012). 
The GAMA is a comprehensive guideline that includes screening for alcohol use and 
dependency using the Fast Alcohol Screening Test (FAST) and a simple numeric score, the 
Glasgow Modified Alcohol Withdrawal Scale (GMAWS) to assess the symptoms of AWS 
(McPherson et al., 2012). The original GAMA study (McPherson et al., 2012) like studies by 
Maldonado et al. (2015), Pecoraro et al. (2013) and Dolman & Hawkes (2005) developed the 
GMAWS to identify escalating withdrawal symptoms for the purpose of hospital treatment 
and not early discharge. The GAMA suggests ADS at FAST greater or equal (≥) 9 and severe 
ADS at FAST ≥ 12 (McPherson et al., 2012). In addition, mild- moderate AWS is reflective 
of GMAWS < 4 and SAWS, GMAWS ≥ 4 (McPherson et al., 2012). The GMAWS and 
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FAST have been validated and tested previously in the NHSGGC hospitals (McPherson et 
al., 2012). 
The aim of this study and described in this paper is to investigate whether the GMAWS and 
the quantitative variables identified through a systematic literature review (Benson et al., 
2019) can be used in the emergency department to help stratifying a person’s risk of 
developing SAWS and support clinicians in their decision to admit or not. The variables 
were; previous SAWS, ARS, DT`s, hours since last drink, age, post code, gender, reason for 
admission, physical observations, blood results, co-morbidities, and level of ADS. Currently 
only one study has explored the use of an alcohol risk stratification tool for the purpose of 
emergency department discharge (Stephens et al., 2014). Because SAWS development is a 
consequence of years of drinking we employed a retrospective method, where risk 
measurement is time from data collection to analysis.  
METHODS
Patients
Patients admitted acutely to the two large Glasgow acute adult hospitals within NHSGGC; 
Queen Elizabeth University Hospital (QEUH) and Glasgow Royal Infirmary (GRI) through 
the emergency department and referred to the AALNS during one calendar month (1st April -
30th April 2016) were retrospectively included in the study. This month was chosen because 
the study was part of a time limited project that coincided with the end of this period. All 
patients were treated using the GAMA guideline and benzodiazepines administered for AWS 
symptoms, and thiamine for treatment and prophylaxis of alcohol related brain damage. ADS 
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was suspected at FAST ≥ 9 and confirmed using ICD-10 classification, while SAWS was 
recognised as GMAWS ≥ 4.  Patients were only counted once and subsequent admissions 
excluded. We also excluded patients who had no documented ICD-10 classification and past 
or present alcohol history. Ethical approval was granted by the NHS West of Scotland 
Research Ethics Committee (16/WS/0194).
Data collection
The medical records of the potential cohort for the study period were reviewed for exclusion 
criteria by a single investigator (AM) using a standard extraction form. The inclusion process 
is shown in Figure 1. Four hundred and eighty nine records related to 432 patients, with only 
the first referral for patients retained. The first admission was used as this patient group are 
frequently admitted to hospital and in a number of occasions this may be recent, and therefore 
prior treatment could adversely impact on the patients presenting GMAWS.  Of the 432 
records only 400 had complete data, which also included ICD-10 classification of ADS. Next, 
a second investigator (GB) reviewed the records and recorded the variables of interest 
identified by the systematic literature review. The GMAWS measured the patients SAWS 
status (GMAWS 0-10) on attendance at the emergency department and during admission. 
SAWS was reflective of GMAWS ≥ 4 and no SAWS, GMAWS < 4 and was supported by the 
total benzodiazepine requirement throughout admission. Any discrepancies were resolved by 
the wider research team. 
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Data Analysis
Data was analysed using the Statistical Package for Social Scientists (SPSS) programme 
version 22. Spearman`s rank correlation coefficient was used to understand the unique 
contribution of the independent variables such as systolic blood pressure (SBP) on the 
dependent variable SAWS status (highest GMAWS). Additionally, as Spearman`s rank 
correlation coefficient does not make assumptions about the distribution of the data it was a 
test recommended when using an ordinal dependent variable such as GMAWS. Standard 
multiple linear regression and stepwise regression was employed to determine how the 
addition of each statistically significant variable (p= <0.05) contributed to the patients SAWS 
status during admission, while controlling for all others. Finally, as the aim of the study was 
to develop a tool to identify low risk of SAWS, there was a need to differentiate between 
SAWS (GMAWS ≥ 4) and no SAWS (GMAWS < 4). Therefore, binary logistic regression 
was performed on the variables to determine how effective they were in predicting the final 
SAWS status based on a dichotomised outcome of SAWS versus no SAWS. Binary logistic 
regression identified the sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV) of the variables that made the greatest contribution to the patients 
SAWS status during admission. 
RESULTS
Cohort (n=400)
We collated the records from 400 patients, where 210 (53%) did not develop SAWS during 
their admission. Table 1 shows that the majority of patients were White Scottish (355/400) 
and the mean age of the cohort was 50 (± 12) years. The cohort was predominantly male (283 
males, 117 females) and co-morbidity was recorded in 212 patient records and more 
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prevalently recorded for patients who did not develop SAWS. Alcohol liver disease (ALD) 
was the most prominent (n=78) co-morbidity in the cohort and almost three quarters of 
patients lived in the two most deprived areas (n=337). The alcohol related conditions of AWS 
(n=190) and ARS (n=45) were the most common reason for admission and self-harm (n=29) 
the most non-alcohol related reason. 
The mean FAST for the cohort was (14± 1.8) while over one third of the cohort records had a 
previous history of ARS recorded (n=138). The mean time since the cohorts last alcoholic 
drink was 30 (± 20) hours and mean alcohol units consumed approximately 196 (± 81) per 
week.  The percentage of males who developed SAWS was greater than those that did not 
develop SAWS (142/190, 75% versus (vs) 141/210, 67%) which was reversed for females 
(48/190, 25% vs 69/210, 33%). The group that developed SAWS tended to be slightly 
younger (49 vs 51 years).   
Table 1 shows that of the blood results alanine aminotransferase (ALT) (r = 0.244, N=398, 
p<0.01), aspartate aminotransferase (AST) (r = 0.209, N=398, p<0.01) and albumin (r = 
0.239, N=398, p<0.01) were significant and positively correlated with SAWS status during 
admission although accounted for only 6%, 4%, and 6% of the outcome. In addition, 
potassium (r = -0.110, N=398, p<0.05) was negatively correlated and responsible for 1% of 
the SAWS status. The physiological markers of systolic blood pressure (SBP) (r=0.427, 
n=398, p<0.01), and pulse (r=0.136, n=398, p<0.01) explained 18% and 2% of the SAWS 
status. 
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FAST (r = 0.243, N=398, p<0.01), GMAWS (r = 0.822, N=398, p<0.01) score at the 
emergency department, and hours since last drink (r = 0.548, N=398, p<0.01) were positively 
correlated with the SAWS status experienced during admission, while previous SAWS (r = - 
0.117, N=398, p<0.05) and ARS (r = - 0.198, N=398, p<0.05) negatively correlated. 
Spearman`s rank correlation identified that in isolation these variables were responsible for 
1% (SAWS) to 68% (GMAWS) of the variance in a patients SAWS status during hospital 
admission. 
The variables, hours since last drink, FAST, GMAWS at the emergency department, previous 
ARS, SAWS, ALT, AST, potassium, albumin, SBP, and pulse where analysed further using 
standard multiple linear regression. The standard multiple linear regression R value for the 11 
variables above was strong (0.843) and accounted for an adjusted R² (squared) that explained 
71% of the SAWS status experienced by patients during their hospital admission: F (11,396) 
= 72.83, p<0.001. However, using stepwise regression, seven of the variables were removed 
as they were not identified as predictor variables: ARS, SAWS, ALT, AST, potassium, 
albumin, and pulse. A significant model emerged that included: hours since last drink, FAST, 
GMAWS, and SBP, F (4,396) = 234.12, p<0.001. Table 2 shows that although the total R² 
adds up to 70%, its components are not unique, where fitting the selected predictors in a 
different order will result in different individual contribution to the same total R² outcome. 
A logistic regression analysis was performed with SAWS status (SAWS = 0, no SAWS = 1) 
as the dependent variable and GMAWS at the emergency department, hours since last drink, 
FAST and SBP as predictor variables.  A total of 400 cases were analysed and the total model 
significantly predicted SAWS status (omnibus chi-square= 316.68, df- 4, p< 0.0005). The 
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model accounted for between 54.7% and 73.0% of the variance in SAWS status, with 89% of 
patients who developed SAWS and 84% of patients not developing SAWS correctly 
predicted. Overall, 87% of predictions were accurate. Table 3 shows that each increase in the 
GMAWS by a score of one is associated with a decrease in the odds of no SAWS by a factor 
of 2.76 (95% CI 2.21, 3.45). In addition,  increasing the time since last drink by 1 hour, 
FAST by a score of 1 and SBP by 1 mmHg increase the odds of SAWS by 1.31 (95% CI 
1.24, 1.37), 1.30 (CI 1.08, 1.57) and 1.22 (95% CI 1.10, 1.34) respectively. 
The study identified that the risk of a patient developing SAWS could be recognised at the 
emergency department with GMAWS ≥ 4, FAST ≥ 15, SBP > 138 mmHg and hours since 
last drink < 44 hours (Table 1) and therefore the risk of not developing SAWS with GMAWS 
< 4, FAST < 15, SBP ≤ 138 mmHg and hours since last drink ≥ 44 hours. 
DISCUSSION
This retrospective cohort study was conducted to capture a population of patients who had a 
prevalent diagnosis of ADS and admitted to two large acute adult hospitals in Glasgow. A 
consequence of ADS is the development of AWS on cessation of alcohol use. AWS spans a 
spectrum that ranges from mild requiring minimal intervention to severe, where hospital 
admission and pharmacological treatment is required (Sutton & Juttel, 2016). Although there 
are tools for the treatment of AWS, their purpose is for the identification and treatment of 
those at high risk of SAWS (Maldonado et al., 2015; Pecoraro et al., 2013; McPherson et al., 
2012: Dolman & Hawkes, 2005). The studies investigating AWS identified that the 
emergency department was a good location to assess SAWS risk and commence treatment 
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(Maldonado et al., 2015; Pecoraro et al., 2013; Eyer et al., 2011; Monte et al., 2010; 
Mennecier et al., 2008; Wright et al., 2006; Lee et al., 2005; Dolman & Hawkes, 2005; Lukan 
et al., 2002; Ferguson et al., 1996; Booth & Blow, 1993). While we agree that the emergency 
department is an ideal location to identify risk, we looked at assessment as an opportunity to 
identify and discharge patients who had ADS and at low risk of SAWS.    
Attendance at the emergency department with AWS is an ideal opportunity to develop a non-
invasive measurement to stratify SAWS risk and discharge low risk patients home. From this 
study, a combination of GMAWS at the emergency department, FAST, hours since last drink 
and SBP appear to be a potential indicator of SAWS risk with sensitivity classification 
showing 84% accuracy in ruling out those without the disease, and 89% specificity ruling in 
those with the disease. 
The results of our study are comparable with the studies by Maldonado et al. (2015), 
Pecoraro et al. (2013) and Dolman and Hawkes (2005), although these studies looked at risk 
stratification for hospital treatment. While the Maldonado et al. (2015) tool comprised of the 
10 most common factors identified from their systematic literature review (Maldonado et al., 
2014), Goodson et al. (2014) in their meta-analysis of 15 studies found that only ARS and 
DT`s where statistically significant in SAWS risk in more than one study.  The lack of 
consistent variables from studies investigating the same phenomenon suggests that the link 
with SAWS was either a chance association or a consequence of poor study design, execution 
or low prevalence. Moreover, although Pecoraro et al. (2013) and Dolman and Hawkes 
(2005) propose that the Alcohol Use Disorder Identification Test (AUDIT) was effective in 
identifying a person’s risk of SAWS, this claim was not supported in other studies (Von-der-
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Pahlen et al., 2008; Shevlin & Smith, 2007; Lima et al., 2005). In contrast to our study these 
published risk stratification tools were based on positive results from small prevalence 
samples (7%; 1.4%; 2%) (Maldonado et al., 2015; Pecoraro et al., 2013; Dolman & Hawkes 
2005). 
The one study by Stephens et al. (2014) that looked at low SAWS risk, unlike our study 
presented a limited systematic literature review that included only three studies. The key to 
the Stephens et al. (2014) process was the   CIWA-AR and like the GMAWS presented 
scores for mild- moderate AWS and SAWS, where the mild to moderate patients were 
discharged home. Previous research has identified that discharge and successful engagement 
with alcohol care and treatment services through a home supported detoxification has been 
associated with a 59% reduction in emergency department attendances and 66% reduction in 
frequent hospital admissions (Tadros et al., 2013; Hughes et al., 2013). However, the 
Stephens et al. (2014) process provided an outpatient detoxification that was unsupported. In 
addition, this process was guided by the CIWA-AR were the predictability for stratifying low 
SAWS risk was not investigated, and therefore risk of adverse events on discharge, unknown. 
Consequently, the number of readmissions within the study population increased. For this 
reason and recognition that the variables in our tool were unable to guarantee no risk, an 
alternative to hospital admission in the form of a home supported detoxification for the 
population discharged from hospital would be explored. 
In the AWS literature the importance of ADS appears to be overlooked, and presented as a 
homogenous concept captured as a single measure by the International Classification of 
Disease (ICD) and the Diagnostic and Statistical Manual of Mental Disorders (DSM) 
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(Maldonado et al., 2015; Pecoraro et al., 2013; Eyer et al., 2011; Monte et al., 2010; 
Mennecier et al., 2008; Wright et al., 2006; Lee et al., 2005; Dolman & Hawkes, 2005; Lukan 
et al., 2002; Ferguson et al., 1996; Booth & Blow, 1993). However, like AWS, ADS spans a 
spectrum where SAWS risk is proportionate to a person’s level of alcohol dependence 
(Stewart & Swain, 2012). Therefore, as a determinant of SAWS the measure of ADS severity 
is paramount as a starting point to understanding risk (Stockwell et al., 1983). Subsequently, 
none of the studies reviewed used a tool to record the severity of the persons ADS in an 
environment where poor alcohol assessment is known (Sutton & Juttel, 2016; Stehman & 
Mycyk, 2013; Forsythe & Lee, 2012). Consequently, it is difficult to exclude the prospect 
that the results and low prevalence of ADS may be as reflective of the quality of assessment 
data as their association with SAWS risk. 
Our study, unlike the AWS literature (Maldonado et al., 2015; Pecoraro et al., 2013; Eyer et 
al., 2011; Monte et al., 2010; Mennecier et al., 2008; Wright et al., 2006; Lee et al., 2005; 
Dolman & Hawkes, 2005; Lukan et al., 2002; Ferguson et al., 1996; Booth & Blow, 1993), 
provided a population where the prevalence of ADS was high. The prevalence of ADS and 
use of FAST as a measure of ADS severity provided a population deemed high risk of 
SAWS. Consequently, the novel concept attributed to this study and not found in the 
literature is the development of a research based tool that can stratify a person’s risk of 
developing SAWS and support clinicians in their decision to admit or discharge low risk 
patients from the emergency department.
The strengths of this study are the accuracy of the data collected by a specialist team of 
alcohol nurses. The retrospective nature of the study supported that GMAWS, FAST, hours 
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since last drink and SBP were not influenced by the aim of the study. The use of a high 
alcohol screening score (FAST ≥ 15) and high withdrawal symptom score (GMAWS ≥ 4) 
seem like reasonable indicators of SAWS risk (McPherson et al., 2012) and therefore FAST < 
15 and GMAWS < 4 indicators of low SAWS risk. While time since last drink as an indicator 
of SAWS risk divides the literature (Maldonado et al. 2015; Eyer et al., 2011; Lee et al., 
2005; Lukan et al., 2002; Ferguson et al., 1996) it is safe to assume that SAWS risk decreases 
with the increase of time (Munchie et al., 2013). However, the impact of SBP is less clear in 
this population where high levels of co-morbidity and subsequent pharmacological treatment 
may have normalised an otherwise abnormal SBP (Chen et al., 2015).  
Despite the strengths of this study there are a number of limitations. First, the study was 
conducted in a single healthcare system that has a high prevalence of ADS, although the 
indicators within the tool are generalisable to other populations. Second, the original GAMA 
study (McPherson et al., 2012) presented high risk of SAWS at FAST ≥ 12, which may have 
resulted in some low risk patients receiving pharmacological intervention influencing their 
SAWS status. Finally, while the risk stratification tool had excellent predictability, the 
included variables were not fully responsible for the variance in whether the patient 
developed SAWS or not, and therefore an alternative treatment pathway is suggested in the 
form of a home supported detoxification. 
The developed risk stratification tool shows considerable promise as a predictor of low risk of 
SAWS and safe discharge from the emergency department. In addition, the risk stratification 
tool includes variables that are collected routinely as part of a patient’s emergency 
department journey. However, further research into the use of this risk stratification tool and 
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the predictor variables are required and should include a prospective cohort study utilising a 
home supported detoxification as an alternative to hospital admission for low risk patients. 
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ABBREVIATIONS
AALNS Acute Addiction Liaison Nursing Service
ADS Alcohol Dependence Syndrome
ALD Alcohol Liver Disease
ALT Alanine aminotransferase
ARS Alcohol Related Seizures
AST Aspartate aminotransferase
AUDIT Alcohol Use Disorder Identification Test
AWS Alcohol Withdrawal Syndrome
CI Confidence Interval
CIWA-Ar Clinical Institute Withdrawal Assessment- Alcohol Revised
DSM Diagnostic and Statistical Manual of Mental Disorders 
DTs Delirium Tremens
FAST Fast Alcohol Screening Test
GRI Glasgow Royal Infirmary
GMAWS Glasgow Modified Alcohol Withdrawal Scale
GAMA Glasgow Assessment Management of Alcohol
ICD-10 International Classification of Disease- Tenth Revision
NHSGGC National Health Service Greater Glasgow & Clyde
NPV Negative Predictive Value
OR Odds Ratio
PAC Percentage Accuracy IN Classification
PPV Positive Predictive Value
QEUH Queen Elizabeth University Hospital
SAWS Severe Alcohol Withdrawal Syndrome
SBP Systolic Blood Pressure
SPSS Statistical Package for Social Scientists
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Figure 1 Algorithm for enrolment of patients for the cohort sample
Total Patients Referred to the Acute Addiction 
Liaison Nursing Service who had a Fast Alcohol 
Screening Test (FAST) ≥ 9 (n= 489)
Total Patients Records included 
(n= 400)
Number of Excluded (n= 89)
Repeat admissions (n= 57)
No International Classification of Disease diagnosis (n= 18)
No hours since last drink (n= 5)
No documentation of previous alcohol related history (Alcohol 
Related Seizure, Severe Alcohol Withdrawal Syndrome, 
Delirium Tremens) (n= 9)
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Male/ female 142/ 48 141/ 69 NS
Mean age at admission (SD) 48.6 (10.54) 50.8 (12.8) NS
White Scottish N (%)
White other British N (%)
White Irish N (%)

















1st quintile (most deprived) N (%)
2nd quintile N (%)
3rd quintile N (%)
4th quintile N (%)
















Employed N (%) 14 (7) 15 (7) NS
Alcohol Liver Disease (ALD) N (%)
Cardiac N (%)
Diabetes N (%)
Cerebral Vascular Disease (CVD) N (%)
Cancer N (%)
Pancreatitis N (%)






















Reason for admission N (%) NS
Alanine aminotransferase (ALT) (U/L) N (SD)
Aspartate aminotransferase (AST) (U/L) N (SD)
Potassium (mmol/l) N (SD)
Platelets (X 10^9/L) N (SD)
















Fast Alcohol Screening Test (FAST) N (SD)
Previous history of Severe alcohol withdrawal 
syndrome (SAWS) ever N (%)
Previous history of alcohol related seizure (ARS) 
ever N (%)














Hours since last drink N (SD) 44.1 (21.66) 17.6 (15.75) 0.0005 
Systolic Blood Pressure (SBP) (mmHg) N (SD)







Data are expressed as mean and  standard deviation (SD) for continuous variables and as frequency (n. %) for categorical variables. 
Only Significant P values (p < 0.05) are presented.  
Severe alcohol withdrawal syndrome (SAWS) was determined as Glasgow Modified Alcohol Withdrawal Scale (GMAWS) ≥ 4 and no 
SAWS, GMAWS < 4
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Glasgow Modified Alcohol 
Withdrawal Scale 
(GMAWS) (1)
0.665 0.035 0.660 0.0005 0.596 0.733 66%
Hours since last drink (2) 0.015 0.003 0.166 0.0005 0.009 0.021 +1 (68)%
Systolic blood pressure 
(SBP) (3)
0.13 0.004 0.131 0.001 0.006 0.021 +1 + 2 (69%)
Fast Alcohol Screening 
Test (FAST) (4)
0.083 0.035 0.071 0.018 0.014 0.152 +1 + 2 + 3 (70%)
R square represents variables identified using stepwise multiple regression. The order and percentage 
contribution to the models predictive ability is presented 
Dependent variable was highest Glasgow Modified Alcohol Withdrawal Scale (GMAWS) score (0-10). The 
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Table 3  Multivariate logistic regression model. Independent clinical predictors in patients 
SAWS status (highest GMAWS)
95% CI for OR




1.016 0.0005 2.762 2.210 3.450
Hours since last drink 0.054 0.0005 1.31 1.24 1.37
Systolic blood pressure 
(SBP)
0.022 0.014 1.22 1.10 1.34
Fast Alcohol Screening 
Test (FAST)
0.265 0.006 1.30 1.08 1.57
 B, Beta, sig, significance, OR, Odds Ratio, CI, Confidence Intervals
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